Cargando…

Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands

In hepatocellular carcinoma (HCC) patients, the intratumoral expression of Toll-like receptor-3 (TLR3) correlates with prolonged survival. We demonstrated that TLR3 ligands can operate through three independent mechanisms: by directly killing TLR3-expressing cancer cells, by inducing T- and natural...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chew, Valerie, Abastado, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654580/ https://www.ncbi.nlm.nih.gov/pubmed/23734310 http://dx.doi.org/10.4161/onci.23493

Ejemplares similares

Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand
por: Préville, Xavier, et al.
Publicado: (2015)

Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D
por: Evans, Elizabeth E, et al.
Publicado: (2015)

The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy
por: Kortylewski, Marcin, et al.
Publicado: (2014)

Toll-like receptor genetic variants and colorectal cancer
por: Weber, Alexander NR, et al.
Publicado: (2014)

How to develop better screens for anti-cancer therapies?
por: Hong, Michelle, et al.
Publicado: (2012)

Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis
por: Kauppila, Joonas H., et al.
Publicado: (2013)

Human papillomavirus (HPV) deregulation of Toll-like receptor 9
por: Hasan, Uzma
Publicado: (2014)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Systemic cancer immunotherapy with Toll-like receptor 7 agonists: Timing is everything
por: Hotz, Christian, et al.
Publicado: (2012)

Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells
por: Berk, Erik, et al.
Publicado: (2014)

Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma
por: Rosa, Roberta, et al.
Publicado: (2013)

Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment
por: Lin, Wen-Jye, et al.
Publicado: (2014)

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

The microenvironment reprograms circuits in tumor cells
por: Cai, Qingchun, et al.
Publicado: (2015)

Local immunomodulation for cancer therapy: Providing treatment where needed
por: Fransen, Marieke F, et al.
Publicado: (2013)

The other face of TLR3: A driving force of breast cancer stem cells
por: Jia, Deyong, et al.
Publicado: (2015)

REG3β contributes to the immunosuppressive microenvironment of pancreatic cancer
por: Folch-Puy, Emma
Publicado: (2013)

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014)

Tumor suppressors control ULBP2, an innate surface ligand of the lymphocyte immune receptor NKG2D
por: Heinemann, Anja, et al.
Publicado: (2012)

Tumor microenvironment in NSCLC suppresses NK cells function
por: Cremer, Isabelle, et al.
Publicado: (2012)

Turning the tumor microenvironment into a self vaccine site
por: Nelson, Delia J.
Publicado: (2012)

Tumor stiffness extends its grip on the metastatic microenvironment
por: Reid, Steven E., et al.
Publicado: (2017)

Warming up the tumor microenvironment in order to enhance immunogenicity
por: Humbert, Marion, et al.
Publicado: (2018)

Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
por: Morello, Silvana, et al.
Publicado: (2014)

Tertiary lymphoid tissue: A gateway for T cells in the tumor microenvironment
por: Di Caro, Giuseppe, et al.
Publicado: (2014)

Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis
por: Lim, Su Yin, et al.
Publicado: (2013)

Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols
por: Raccosta, Laura, et al.
Publicado: (2013)

Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
por: Chew, Valerie, et al.
Publicado: (2012)

New strategies for melanoma immunotherapy: How to overcome immunosuppression in the tumor microenvironment
por: Umansky, Viktor
Publicado: (2012)

Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists
por: Luheshi, Nadia, et al.
Publicado: (2014)

The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013)

Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison
por: Conrad, Curdin, et al.
Publicado: (2013)

Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment
por: Jinushi, Masahisa
Publicado: (2012)

Signaling via MYD88 in the pancreatic tumor microenvironment: A double-edged sword
por: Zambirinis, Constantinos P., et al.
Publicado: (2013)

Toll-Like Receptor 3 Expressing Tumor Parenchyma and Infiltrating Natural Killer Cells in Hepatocellular Carcinoma Patients
por: Chew, Valerie, et al.
Publicado: (2012)

Pancreatic cancer-associated stellate cells: A viable target for reducing immunosuppression in the tumor microenvironment
por: Mace, Thomas A, et al.
Publicado: (2013)

RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment
por: Said, Neveen, et al.
Publicado: (2012)

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
por: Bellone, Matteo, et al.
Publicado: (2013)

Membrane-bound KIT ligand-targeting DNA vaccination inhibits mammary tumor growth
por: Dentelli, Patrizia, et al.
Publicado: (2014)

Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancer
por: Ijichi, Hideaki
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_plfiupptc55ee796111b63rshv